Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp ® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis
Condition: Chronic Kidney Disease Intervention: Biological: Stimus Sponsors: Nanogen Pharmaceutical Biotechnology Joint Stock Company; Vietstar Biomedical Research; Clinical Research Consultants, Inc.; Clinical Research Viet Nam Skill Training And Consultant Company Limited Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Aranesp | Biotechnology | Dialysis | Nanotechnology | Research | Training | Universities & Medical Training | Urology & Nephrology